Halozyme Therapeutics, Inc. (NASDAQ:HALO) Q4 2022 Earnings Conference Call February 21, 2023 4:30 PM ET Company Participants Tram Bui - Vice President, Investor Relations and Corporate Communications Dr. Helen Torley - President and CEO Nicole LaBrosse - Chief Financial Officer Conference Call Participants Mohit Bansal - Wells Fargo Mike DiFiore - Evercore ISI Jason Butler - JMP Securities Jessica Fye - JPMorgan Corinne Jenkins - Goldman Sachs Vikram Purohit - Morgan Stanley Dan Tarjan - SVB Securities Oper ...